Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Profiles of circulating microRNA in the plasma of patients with prostate cancer with pathomorphological stages pT2, pT3, and pT4 are analyzed. The level of circulating microRNA hsa-miR-619-5p is elevated in patients with extracapsular spreading of the tumor, increasing significantly from stage pT2 to stage pT4.

Об авторах

M. Shkurnikov

BioClinicum Research Centre; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia

Автор, ответственный за переписку.
Email: mshkurnikov@gmail.com
Россия, Moscow; Moscow

Yu. Makarova

BioClinicum Research Centre

Email: mshkurnikov@gmail.com
Россия, Moscow

E. Knyazev

BioClinicum Research Centre; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia

Email: mshkurnikov@gmail.com
Россия, Moscow; Moscow

K. Fomicheva

P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia

Email: mshkurnikov@gmail.com
Россия, Moscow

A. Galatenko

BioClinicum Research Centre

Email: mshkurnikov@gmail.com
Россия, Moscow

K. Nyushko

P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia

Email: mshkurnikov@gmail.com
Россия, Moscow

V. Galatenko

BioClinicum Research Centre

Email: mshkurnikov@gmail.com
Россия, Moscow

V. Vechorko

Federal Research Institute of Health Organization and Informatics, Ministry of Health of the Russian Federation

Email: mshkurnikov@gmail.com
Россия, Moscow

B. Alekseev

P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia

Email: mshkurnikov@gmail.com
Россия, Moscow


© Springer Science+Business Media, LLC, 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах